send to a friend by email

JPH posts net income of $3.90 million in 9M 2022

2022-11-13

According to the financial statements of Jerusalem Pharmaceuticals Company JPH for the first nine months of 2022, Net profit after tax of the period reached 3,900,803 USD Compared with Net profit after tax 2,698,334 USD for 2021, a net increase in profit of 44.56%.Total assets of the company reached 83,282,596 USD compared with total assets of 86,892,982 USD at the end of year 2021, a net decrease of 4.16%.Total liabilities of the company reached 19,746,462 USD compared with total liabilities of 18,323,461 USD at the end of year 2021, a net increase of 7.76%. Net ownership equity of the company reached 63,536,134 USD (Including Non-Controlling Interests of 1,983,771 USD) compared with total owner equity of 68,569,521 USD (Including Non-Controlling Interests of 2,097,384 USD) at the end of year 2021, a net decrease of 7.34%.